Sarah Sheehan (they/them) is a Program Lead for the Digital Medicine Society (DiMe) where their work focuses on the use of digital health tools to enable high-quality clinical evidence generation and care delivery in oncology. Previously, Sarah was an Assistant Research Director at the Duke University Margolis Center for Health Policy leading biomedical innovation and regulatory science initiatives. At Duke, they oversaw a portfolio of work related to clinical trial modernization and improved evidence generation, with core efforts on the integration of clinical research and clinical care using real world data, the engagement of community health systems in clinical research, and approaches to achieving representative clinical trial enrollment. Before joining Duke, Sarah was a Health Policy Analyst at the United States Government Accountability Office (GAO) and a Researcher at the Centers for Disease Control and Prevention (CDC). At GAO and CDC, Sarah’s research covered policies for incentivizing the development of new antimicrobials as well as approaches for supporting antimicrobial stewardship efforts and the prevention of healthcare-associated infections. Sarah has a Masters degree in Public Administration and Policy as well as Bachelors degrees in International Affairs and Political Science from The University of Georgia.